Genmab A/S Cash And Cash Equivalents
Genmab A/S (GNMSF) had Cash And Cash Equivalents of $1.72 billion as of 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-02-17
- 2024-12-31: Cash And Cash Equivalents 9.86B DKK.
- 2024-06-30: Cash And Cash Equivalents 4.33B DKK.
- 2023-12-31: Cash And Cash Equivalents 14.87B DKK.
- 2023-06-30: Cash And Cash Equivalents 10.87B DKK.
DKK
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2024-12-31 | 9.86B DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 4.33B DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 14.87B DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 10.87B DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 9.89B DKK 6-K · filed 2025-02-12 | |
| 2022-06-30 | 9.82B DKK 6-K · filed 2023-08-03 | |
| 2021-12-31 | 8.96B DKK 6-K · filed 2025-02-12 | |
| 2021-06-30 | 9.48B DKK 6-K · filed 2022-08-10 | |
| 2020-12-31 | 7.26B DKK 6-K · filed 2024-02-14 | |
| 2020-06-30 | 6.61B DKK 6-K · filed 2021-08-11 | |
| 2019-12-31 | 3.55B DKK 6-K · filed 2023-02-22 | |
| 2019-06-30 | 583.00M DKK 6-K · filed 2020-08-12 | 582.86M DKK 6-K · filed 2019-08-14 |
| 2018-12-31 | 533.00M DKK 6-K · filed 2022-02-16 | 532.91M DKK 6-K · filed 2019-08-14 |
| 2018-06-30 | 1.09B DKK 6-K · filed 2019-08-14 | |
| 2017-12-31 | 1.35B DKK 6-K · filed 2021-02-23 | 1.35B DKK 6-K · filed 2019-08-14 |
| 2016-12-31 | 307.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $1.72B 20-F · filed 2026-02-17 |
| 2025-06-30 | $1.30B 6-K · filed 2025-08-07 |
| 2024-12-31 | $1.38B 20-F · filed 2026-02-17 |
| 2024-06-30 | $622.00M 6-K · filed 2025-08-07 |
| 2023-12-31 | $2.20B 20-F · filed 2026-02-17 |
| 2022-12-31 | $1.42B 20-F · filed 2026-02-17 |